相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Inhibition studies with simple and complex (in)organic anions of the γ-carbonic anhydrase from Mammaliicoccus (Staphylococcus) sciuri, MscCAγ
Simone Giovannuzzi et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)
Emerging compounds and therapeutic strategies to treat infections from Trypanosoma brucei: an overhaul of the last 5-years patents
Francesco Melfi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2023)
Organoboronic acids/esters as effective drug and prodrug candidates in cancer treatments: challenge and hope
Mothana K. Al-Omari et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)
6-Substituted Triazolyl Benzoxaboroles as Selective Carbonic Anhydrase Inhibitors: In Silico Design, Synthesis, and X-ray Crystallography
Alessio Nocentini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2023)
The Dawn of a New Era: Tumor-Targeting Boron Agents for Neutron Capture Therapy
Ting Luo et al.
MOLECULAR PHARMACEUTICS (2023)
Boron-Containing heterocycles as promising pharmacological agents
Bhaskar C. Das et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2022)
The inhibitory effect of boric acid on hypoxia-regulated tumour-associated carbonic anhydrase IX
Zainab Saad Yusuf et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Cloning, purification, kinetic and anion inhibition studies of a recombinant β-carbonic anhydrase from the Atlantic salmon parasite platyhelminth Gyrodactylus salaris
Ashok Aspatwar et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Boron Chemicals in Drug Discovery and Development: Synthesis and Medicinal Perspective
Bhaskar C. Das et al.
MOLECULES (2022)
The Boron Advantage: The Evolution and Diversification of Boron's Applications in Medicinal Chemistry
Katia Messner et al.
PHARMACEUTICALS (2022)
Determination of acidity constants, ionic mobilities, and hydrodynamic radii of carborane-based inhibitors of carbonic anhydrases by capillary electrophoresis
Veronika Solinova et al.
ELECTROPHORESIS (2021)
Anion inhibition studies of the Zn(II)-bound ι-carbonic anhydrase from the Gram-negative bacterium Burkholderia territorii
Andrea Petreni et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Recent developments in the medicinal chemistry of single boron atom-containing compounds
Shu Song et al.
ACTA PHARMACEUTICA SINICA B (2021)
Boron Neutron Capture Therapy: A Review of Clinical Applications
Timothy D. Malouff et al.
FRONTIERS IN ONCOLOGY (2021)
Inhibitors of CA IX Enzyme Based on Polyhedral Boron Compounds
Michael Kugler et al.
CHEMBIOCHEM (2021)
Novel carbonic anhydrase inhibitors
Claudiu T Supuran
FUTURE MEDICINAL CHEMISTRY (2021)
The modern role of boron as a 'magic element' in biomedical science: chemistry perspective
Saurav Chatterjee et al.
CHEMICAL COMMUNICATIONS (2021)
An overview on the recently discovered iota-carbonic anhydrases
Alessio Nocentini et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Emerging role of carbonic anhydrase inhibitors
Claudiu T. Supuran
CLINICAL SCIENCE (2021)
An anion and small molecule inhibition study of the β-carbonic anhydrase from Staphylococcus aureus
Linda J. Urbanski et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Anion inhibition studies of the α-carbonic anhydrases from Neisseria gonorrhoeae
Alessio Nocentini et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Boron Chemistry for Medical Applications
Fayaz Ali et al.
MOLECULES (2020)
Sulfonamide Inhibition Profile of the β-Carbonic Anhydrase from Malassezia restricta, An Opportunistic Pathogen Triggering Scalp Conditions
Sonia Del Prete et al.
METABOLITES (2020)
Anion Inhibition Studies of the beta-Class Carbonic Anhydrase CAS3 from the Filamentous Ascomycete Sordaria macrospora
Daniela Vullo et al.
METABOLITES (2020)
Sulfonamido carboranes as highly selective inhibitors of cancer-specific carbonic anhydrase IX
Jana Dvoranova et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Direct Introduction of an Alkylsulfonamido Group on C-sites of Isomeric Dicarba-closo-dodecaboranes: The Influence of Stereochemistry on Inhibitory Activity against the Cancer-Associated Carbonic Anhydrase IX Isoenzyme
Jan Nekvinda et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
Design and discovery of boronic acid drugs
Jessica Plescia et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Anion Inhibition Studies of the Beta-Carbonic Anhydrase from Escherichia coli
Sonia Del Prete et al.
MOLECULES (2020)
Benzoxaboroles: New Potent Inhibitors of the Carbonic Anhydrases of the Pathogenic Bacterium Vibrio cholerae
Alessandro Bonardi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Elucidating the role of metal ions in carbonic anhydrase catalysis
Jin Kyun Kim et al.
NATURE COMMUNICATIONS (2020)
Inhibition of the newly discovered β-carbonic anhydrase from the protozoan pathogen Trichomonas vaginalis with inorganic anions and small molecules
Linda J. Urbanski et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2020)
In vitro and in vivo BNCT investigations using a carborane containing sulfonamide targeting CAIX epitopes on malignant pleural mesothelioma and breast cancer cells
Diego Alberti et al.
SCIENTIFIC REPORTS (2020)
The structural basis for the selectivity of sulfonamido dicarbaboranes toward cancer-associated carbonic anhydrase IX
Michael Kugler et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Onychomycosis Treatment and prevention of recurrence
Shari R. Lipner et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
TERT gene: its function and dysregulation in cancer
Andrew J. Colebatch et al.
JOURNAL OF CLINICAL PATHOLOGY (2019)
Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor
Pek Y. Chong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Application of Topical Phosphodiesterase 4 Inhibitors in Mild to Moderate Atopic Dermatitis A Systematic Review and Meta-analysis
Huan Yang et al.
JAMA DERMATOLOGY (2019)
Bis-benzoxaboroles: Design, Synthesis, and Biological Evaluation as Carbonic Anhydrase Inhibitors
Adele Larcher et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial
Robert Bissonnette et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Metallacarborane Sulfamides: Unconventional, Specific, and Highly Selective Inhibitors of Carbonic Anhydrase IX
Bohumir Gruner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Boron in drug design: Recent advances in the development of new therapeutic agents
Guilherme Felipe Santos Fernandes et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Multivalent Carbonic Anhydrases Inhibitors
Fabrizio Carta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Protonography and anion inhibition profile of the α-carbonic anhydrase (CruCA4) identified in the Mediterranean red coral Corallium rubrum
Sonia Del Prete et al.
BIOORGANIC CHEMISTRY (2018)
Benzoxaborole compounds for therapeutic uses: a patent review (2010-2018)
Alessio Nocentini et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Anion inhibition studies of a beta carbonic anhydrase from the malaria mosquito Anopheles gambiae
Daniela Vullo et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
353Evaluation of the pharmacokinetics and pharmacodynamics of subcutaneously administered dutogliptin for daily injection with granulocyte colony stimulating factor (G-CSF) for AMI
D Nix et al.
EUROPEAN HEART JOURNAL (2018)
Comparison of the Anion Inhibition Profiles of the α-CA Isoforms (SpiCA1, SpiCA2 and SpiCA3) from the Scleractinian Coral Stylophora pistillata
Sonia Del Prete et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Advances in structure-based drug discovery of carbonic anhydrase inhibitors
Claudiu T. Supuran
EXPERT OPINION ON DRUG DISCOVERY (2017)
Carbonic anhydrases from Trypanosoma cruzi and Leishmania donovani chagasi are inhibited by benzoxaboroles
Alessio Nocentini et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Discovery of a Potent and Specific M-tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)
Xianfeng Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Benzoxaboroles as Efficient Inhibitors of the β-Carbonic Anhydrases from Pathogenic Fungi: Activity and Modeling Study
Alessio Nocentini et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Bortezomib inhibits mammalian carbonic anhydrases
Claudiu T. Supuran
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Anion inhibitors of the β-carbonic anhydrase from the pathogenic bacterium responsible of tularemia, Francisella tularensis
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Effective Access to Multivalent Inhibitors of Carbonic Anhydrases Promoted by Peptide Bioconjugation
Nasreddine Kanfar et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Anion inhibition profiles of the γ-carbonic anhydrase from the pathogenic bacterium Burkholderia pseudomallei responsible of melioidosis and highly drug resistant to common antibiotics
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Effects of dipotassium-trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], on cell viability and gene expression of common human cancer drug targets in a melanoma cell line
Lejla Pojskic et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Cloning, characterization and anion inhibition studies of a γ-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea
Viviana De Luca et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Anion inhibition profiles of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Bortezomib inhibits bacterial and fungal β-carbonic anhydrases
Claudiu T. Supuran
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Benzoxaborole as a new chemotype for carbonic anhydrase inhibition
Vincenzo Alterio et al.
CHEMICAL COMMUNICATIONS (2016)
An Overview of the Carbonic Anhydrases from Two Pathogens of the Oral Cavity: Streptococcus mutans and Porphyromonas gingivalis
Clemente Capasso et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Recent developments with boron as a platform for novel drug design
Zbigniew J. Lesnikowski
EXPERT OPINION ON DRUG DISCOVERY (2016)
Legionella pneumophila Carbonic Anhydrases: Underexplored Antibacterial Drug Targets
Claudiu T. Supuran
PATHOGENS (2016)
Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa
Melissa A. Pinard et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Boron-Based Drug Design
Hyun Seung Ban et al.
CHEMICAL RECORD (2015)
Poly(amidoamine) Dendrimers with Carbonic Anhydrase Inhibitory Activity and Antiglaucoma Action
Fabrizio Carta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Emerging trends in enzyme inhibition by multivalent nanoconstructs
Nasreddine Kanfar et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2015)
Dipotassium-trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], is a potent inhibitor of human carbonic anhydrases
Daniela Vullo et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Cloning, characterization and anion inhibition study of the δ-class carbonic anhydrase (TweCA) from the marine diatom Thalassiosira weissflogii
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum-The η-carbonic anhydrases
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Crystal structures of two tetrameric β-carbonic anhydrases from the filamentous ascomycete Sordaria macrospora
Ronny Lehneck et al.
FEBS JOURNAL (2014)
Anion inhibition studies of a β-carbonic anhydrase from Clostridium perfringens
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Kinetic and anion inhibition studies of a β-carbonic anhydrase (FbiCA 1) from the C4 plant Flaveria bidentis
Simona Maria Monti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
QM/MM Calculations Reveal the Different Nature of the Interaction of Two Carborane-Based Sulfamide Inhibitors of Human Carbonic Anhydrase II
Adam Pecina et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2013)
The first activation study of a bacterial carbonic anhydrase (CA). The thermostable α-CA from Sulfurihydrogenibium yellowstonense YO3AOP1 is highly activated by amino acids and amines
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Anion inhibition studies of an α-carbonic anhydrase from the living fossil Astrosclera willeyana
Anna Ohradanova et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Inhibition of beta-carbonic anhydrases from the bacterial pathogen Brucella suis with inorganic anions
Alfonso Maresca et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
(In)organic anions as carbonic anhydrase inhibitors
Giuseppina De Simone et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII
Marouan Rami et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata
Anthony Bertucci et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Carbonic anhydrase inhibitors. Inhibition of transmembrane isoforms IX, XII, and XIV with less investigated anions including trithiocarbonate and dithiocarbamate
Alessio Innocenti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Carbonic anhydrase inhibitors: Crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mammalian isoforms I-XV
Anna Di Fiore et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isoforms I and II and transmembrane, tumor-associated isoforms IX and XII with boronic acids
Jean-Yves Winuma et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Carbonic anhydrase inhibitors. Inhibition of the fungal β-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids
Alessio Innocenti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Therapeutic potential of boron-containing compounds
Stephen J. Baker et al.
FUTURE MEDICINAL CHEMISTRY (2009)
Comparative effects of boric acid and calcium fructoborate on breast cancer cells
R. Scorei et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2008)
Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer
Bruce D. Dorsey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer
Kalyani Narra et al.
CANCER BIOLOGY & THERAPY (2007)
The role of fluorine in medicinal chemistry
Poonam Shah et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2007)
United States Food and Drug Administration approval summary: Bortezomib for the treatment of progressive multiple myeloma after one prior therapy
Robert C. Kane et al.
CLINICAL CANCER RESEARCH (2006)
Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: Toward agents for boron neutron capture therapy of hypoxic tumors
JY Winum et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
The proteasome: A suitable antineoplastic target
J Adams
NATURE REVIEWS CANCER (2004)
Boric acid inhibits human prostate cancer cell proliferation
WT Barranco et al.
CANCER LETTERS (2004)
Carbonic anhydrase inhibitors, interaction of boron derivatives with isozymes I and II: A new binding site for hydrophobic inhibitors at the entrance of the active site as shown by docking studies
C Chazalette et al.
JOURNAL OF ENZYME INHIBITION (2001)
Carbonic anhydrase inhibitors: Allylsulfonamide, styrene sulfonamide, N-allyl sulfonamides and some of their Si, Ge, and B derivatives
C Chazalette et al.
JOURNAL OF ENZYME INHIBITION (2001)